EMA Authorised: Cuprior (trientine tetrahydrochloride) — Orphalan

View source ↗

Summary

Cuprior (trientine tetrahydrochloride) has been authorised in the European Union for hepatolenticular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatolenticular Degeneration

Drugs mentioned

• Cuprior (trientine)

Snippet

Status: Authorised. Therapeutic area: Hepatolenticular Degeneration. MAH: Orphalan. Decision date: 25/03/2024